NOX4 and prostate cancer: Preradiation treatment of human prostate cancer cells with Nox inhibitors sensitized the cells to radiation similar to androgen deprivation therapy [13], further supporting the notion that enhanced Nox4 levels are protective against radiation-induced tumor cell death.